These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 38446216
1. Network pharmacology and experimental verification study on the mechanism of Hedyotis diffusa Willd in treating colorectal cancer. Yuan X, Huang H, Yu C, Tang Z, Li Y. Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6507-6521. PubMed ID: 38446216 [Abstract] [Full Text] [Related]
2. Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation. Wang T, Zhang W, Fang C, Wang N, Zhuang Y, Gao S. Curr Comput Aided Drug Des; 2024 Sep; 20(5):486-500. PubMed ID: 37287284 [Abstract] [Full Text] [Related]
3. The immunotherapy mechanism of Hedyotis Diffusae Herba in treating liver cancer: a study based on network pharmacology, bioinformatics, and experimental validation. Zheng Q, Wu X, Peng S. Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug 02. PubMed ID: 39093467 [Abstract] [Full Text] [Related]
4. Mechanism of Sophorae Flavescentis Radix against ovarian cancer via new pharmacology, molecular docking, and experimental verification. Fu X, Liang F. Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep 02; 397(9):6837-6850. PubMed ID: 38561549 [Abstract] [Full Text] [Related]
5. Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach. Song Y, Wang H, Pan Y, Liu T. Biomolecules; 2019 Oct 09; 9(10):. PubMed ID: 31600936 [Abstract] [Full Text] [Related]
6. Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer. Wu Z, Zhu Z, Fu L. Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun 09; 397(6):4165-4181. PubMed ID: 38032489 [Abstract] [Full Text] [Related]
7. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis. Zhuang Y, Sun YG, Wang CG, Zhang Q, Che C, Shao F. Curr Drug Targets; 2024 Jun 09; 25(6):431-443. PubMed ID: 38213161 [Abstract] [Full Text] [Related]
8. Exploring the immunological mechanism of Houttuynia cordata in the treatment of colorectal cancer through combined network pharmacology and experimental validation. Li Y, Wu J, Jiang S, Wang N. Naunyn Schmiedebergs Arch Pharmacol; 2024 Nov 09; 397(11):9095-9110. PubMed ID: 38888753 [Abstract] [Full Text] [Related]
9. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway. Xu X, Chen F, Zhang L, Liu L, Zhang C, Zhang Z, Li W. J Ethnopharmacol; 2021 Oct 28; 279():114343. PubMed ID: 34147618 [Abstract] [Full Text] [Related]
10. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology]. Li JL, Hou W. Zhongguo Zhong Yao Za Zhi; 2021 Dec 28; 46(23):6261-6270. PubMed ID: 34951253 [Abstract] [Full Text] [Related]
11. Hedyotis diffusa Willd and Astragalus membranaceus May Exert Anti-colon Cancer Effects by Affecting AKTI Expression, as Determined by Network Pharmacology and Molecular Docking. Ren J, Mo Z, Huang Z, Li S. Curr Comput Aided Drug Des; 2024 Apr 17. PubMed ID: 38638040 [Abstract] [Full Text] [Related]
12. [Mechanism of Huachansu Injection against colorectal cancer based on network pharmacology and cellular experimental]. Meng ZY, Zhao J, Zhu QF, Xiang DF, Meng JJ, Chen JJ, Jiang B, Hu YJ, Xu LY, Zhang XQ, Zou H, Han YL. Zhongguo Zhong Yao Za Zhi; 2024 Sep 17; 49(17):4755-4767. PubMed ID: 39307810 [Abstract] [Full Text] [Related]
13. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma via Singlecell RNA Sequencing and Network Pharmacology. Bai Y, Chen R, Sun J, Guo Y. Comb Chem High Throughput Screen; 2024 Sep 17; 27(6):910-921. PubMed ID: 37526191 [Abstract] [Full Text] [Related]
14. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation. Lu S, Sun X, Zhou Z, Tang H, Xiao R, Lv Q, Wang B, Qu J, Yu J, Sun F, Deng Z, Tian Y, Li C, Yang Z, Yang P, Rao B. Front Immunol; 2023 Sep 17; 14():1235575. PubMed ID: 37799727 [Abstract] [Full Text] [Related]
15. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway. Li Q, Lai Z, Yan Z, Peng J, Jin Y, Wei L, Lin J. Mol Med Rep; 2018 Jan 17; 17(1):358-365. PubMed ID: 29115462 [Abstract] [Full Text] [Related]
16. Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies. Yan H, Li Y, Yang B, Long F, Yang Z, Tang D. Biotechnol Genet Eng Rev; 2023 Oct 17; 39(2):1107-1127. PubMed ID: 36735641 [Abstract] [Full Text] [Related]
17. Hedyotis diffusa Willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway. Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan Y, Zeng J, Xu W, Shen A, Hong Z, Peng J. Int J Mol Sci; 2012 Oct 17; 13(5):6117-6128. PubMed ID: 22754353 [Abstract] [Full Text] [Related]
18. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies. Mu BX, Li Y, Ye N, Liu S, Zou X, Qian J, Wu C, Zhuang Y, Chen M, Zhou JY. J Ethnopharmacol; 2024 Jan 30; 319(Pt 3):117342. PubMed ID: 37879505 [Abstract] [Full Text] [Related]
19. Pharmacological mechanism of quercetin in the treatment of colorectal cancer by network pharmacology and molecular simulation. Fu L, Zhao L, Li F, Wen F, Zhang P, Yang X, Wang Y. J Biomol Struct Dyn; 2024 Aug 30; 42(13):7065-7076. PubMed ID: 37464874 [Abstract] [Full Text] [Related]
20. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer. Huang S, Zhang Z, Li W, Kong F, Yi P, Huang J, Mao D, Peng W, Zhang S. Drug Des Devel Ther; 2020 Aug 30; 14():2725-2740. PubMed ID: 32764874 [Abstract] [Full Text] [Related] Page: [Next] [New Search]